SynthesisEuropean journal of clinical pharmacology2023

Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes.

Dengpiao Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.